AIXC logo

AIXC AIxCrypto Holdings, Inc.

NASDAQ Capital Market · Software - Infrastructure · Technology

$1.37
+0.24 (+21.24%)

AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tu…

Market Cap: $27.72Mwww.aixcrypto.ai

Price

$0.82-41.29%
$0.65$0.93$1.22$1.50
Apr 29Aug 7

Social Signal Score

56
5d
—
30d
—
60d
—
90d
56
4 mentions
+0.0%
news: 4

Revenue

$4.5K
$0.00$633.2K$1.27M$1.90M
Sep 2017Sep 2026

Analyst Estimates

FY2025
$-35.50
$-35.50–$-35.50
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Jiawei Wang
Sector
Technology
Industry
Software - Infrastructure
Employees
10
Beta
0.57
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-33.69
www.aixcrypto.ai